Subtype
Blood Vessel Neoplasm
CI-CAN-00000567Explore in graph →
Non-malignant50 active trials4 approved drugs8 evidence items
- NCIt
- C7387
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000567Explore in graph →
Clinical trials
292 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06677853 | Timolol Maleate Gel for the Treatment of Infantile Hemangioma | completed | Phase 2 / Phase 3 | 168 | Auson Pharmaceuticals Inc.INDUSTRY | 1 | Nov 7, 2024 | clinicaltrials |
| NCT01685398 | Topical Timolol for Superficial Infantile Hemangioma | completed | Phase 3 | 48 | Mahidol UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT02342275 |
| Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma |
| completed |
| Phase 3 |
| 377 |
| West China HospitalOTHER |
| 1 |
| Jun 16, 2022 |
| clinicaltrials |
| NCT00346164 | Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma | completed | Phase 3 | 588 | Children's Oncology GroupNETWORK | 5 | Apr 28, 2022 | clinicaltrials |
| NCT02505971 | Nadolol Versus Propranolol in Children With Infantile Hemangiomas | completed | Phase 3 | 74 | The Hospital for Sick ChildrenOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT02979899 | Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma(TAPPAS) | completed | Phase 3 | 128 | Tracon Pharmaceuticals Inc.INDUSTRY | 8 | May 12, 2020 | clinicaltrials |
| NCT01352117 | Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma(REACT-KS) | completed | Phase 3 | 192 | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsNETWORK | 6 | Nov 14, 2019 | clinicaltrials |
| NCT00312520 | Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of Infancy | completed | Phase 3 | 20 | The Hospital for Sick ChildrenOTHER | 1 | Apr 19, 2018 | clinicaltrials |
| NCT01056341 | Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy | completed | Phase 2 / Phase 3 | 512 | Pierre Fabre DermatologyINDUSTRY | 16 | Dec 10, 2015 | clinicaltrials |
| NCT00834457 | A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe | completed | Phase 2 / Phase 3 | 49 | Parirenyatwa HospitalOTHER | 1 | Oct 30, 2014 | clinicaltrials |
| NCT00003350 | Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma | completed | Phase 3 | 240 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00002093 | A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. | completed | Phase 3 | — | Nexstar PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002105 | Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma | completed | Phase 3 | 220 | Sequus PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002147 | Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma. | completed | Phase 3 | — | Sequus PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002319 | A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma | completed | Phase 3 | — | Sequus PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002445 | Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients | completed | Phase 3 | 200 | CytranINDUSTRY | 4 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Nov 7, 2024source: clinicaltrials